Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-08
1996-09-17
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546156, 546160, 546161, A61K 3147, C07D21530
Patent
active
055568637
ABSTRACT:
The present invention relates to novel quinoline derivatives of the formula ##STR1## which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.
REFERENCES:
patent: 4011332 (1977-03-01), Schoetensack et al.
patent: 4042702 (1977-08-01), Rainer et al.
patent: 4093812 (1978-06-01), Rainer et al.
patent: 4120966 (1978-10-01), Brown et al.
patent: 4239901 (1980-12-01), Rainer et al.
patent: 4243678 (1981-01-01), Krastinat et al.
patent: 4250183 (1981-02-01), Krastinat et al.
patent: 4272507 (1981-06-01), Figala et al.
patent: 4317823 (1982-03-01), Rainer et al.
patent: 4324796 (1982-04-01), Eistetter et al.
patent: 4334089 (1982-06-01), Kraas et al.
patent: 4337267 (1982-06-01), Eistetter et al.
patent: 4343804 (1982-08-01), Munson
patent: 4363816 (1982-12-01), Senn-Bilfinger
patent: 4381301 (1983-04-01), Rainer et al.
patent: 4395414 (1983-07-01), Eistetter et al.
patent: 4430339 (1984-02-01), Eistetter et al.
patent: 4578381 (1986-03-01), Uchida et al.
patent: 4738970 (1988-04-01), Uchida et al.
patent: 4806550 (1989-02-01), Ife et al.
patent: 4935431 (1990-06-01), Ife et al.
patent: 5006535 (1991-04-01), Ife et al.
patent: 5049567 (1991-09-01), Ife et al.
patent: 5051508 (1991-09-01), Brown et al.
patent: 5064833 (1991-11-01), Ife et al.
patent: 5082841 (1992-01-01), Brown et al.
patent: 5082848 (1992-01-01), Ife et al.
patent: 5089498 (1992-02-01), Ife et al.
patent: 5102892 (1992-04-01), Geiss et al.
patent: 5143920 (1992-09-01), Ife et al.
patent: 5200417 (1993-04-01), Brown et al.
patent: 5215999 (1993-06-01), Uchida et al.
patent: 5250527 (1993-10-01), Ife et al.
C. A. Leach et al. "Reversible in inhibitors of the gastric (H+/K+)-At Pase." Med. Chem. 1995, 38, 2748-62.
R. J. Ife et al. "SAR of 3-Acryl-4-(Arylamine) guirolimes . . . " 5th Cypress conference New Meth. May 1992 and poster, p. 34.
Astra Aktiebolag
Ivy C. Warren
M. Mach D. Margaret
LandOfFree
Compound for gastric acid secretion inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compound for gastric acid secretion inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound for gastric acid secretion inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413343